Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1996-8-26
pubmed:abstractText
It is now established that the lysine binding site (LBS) of apo(a) kringle IV-10, and particularly Trp72, plays a dominant role in the binding of lipoprotein(a) [Lp(a)] to lysine. To determine the role of the LBS in the binding of Lp(a) to fibrinogen, we examined the binding to plasmin-modified (PM) fibrinogen of human and rhesus monkey Lp(a) species classified as either Lys' or Lys- based on their capacity to bind lysine Sepharose and to have Trp or Arg, respectively, in position 72 of the LBS of kringle IV-10. We also examined the free apo(a)s obtained by subjecting their corresponding parent Lp(a)s to a mild reductive procedure developed in our laboratory. Our results show that both Lyst and Lys- Lp(a)s and their derived apo(a)s, bound to PM-fibrinogen with similar affinities (Kds: 33-100 nM), whereas the B(max) values were threefold higher for apo(a)s. Both the lysine analog epsilon-aminocaproic acid and L-proline inhibited the binding of Lp(a) and apo(a) to PM fibrinogen. We conclude that the LBS of kringle IV-10 is not involved in this process and that apo(a) binds to PM-fibrinogen via a lysine-proline-sensitive domain located outside the LBS and largely masked by the interaction of apo(a) with apoB100. The significant difference in the PM fibrinogen binding capacity also suggests that apo(a) may have a comparatively higher athero-thrombogenic potential than parent Lp(a).
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-1627572, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-1645755, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-1677272, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-1829751, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-1848551, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2140835, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2149268, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2524834, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2525378, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2527286, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2528948, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2789507, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2925643, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-2999280, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-3472206, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-3670400, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-6833255, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-7742349, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-7779780, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-7890760, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-7918682, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-7947758, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-7998944, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8063825, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8073042, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8187246, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8329699, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8423225, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8578490, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8630665, http://linkedlifedata.com/resource/pubmed/commentcorrection/8690792-8845377
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
185-91
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8690792-6-Aminocaproic Acid, pubmed-meshheading:8690792-Adult, pubmed-meshheading:8690792-Aged, pubmed-meshheading:8690792-Animals, pubmed-meshheading:8690792-Apolipoproteins, pubmed-meshheading:8690792-Apoprotein(a), pubmed-meshheading:8690792-Binding, Competitive, pubmed-meshheading:8690792-Binding Sites, pubmed-meshheading:8690792-Dose-Response Relationship, Drug, pubmed-meshheading:8690792-Female, pubmed-meshheading:8690792-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:8690792-Humans, pubmed-meshheading:8690792-Kringles, pubmed-meshheading:8690792-Lipoprotein(a), pubmed-meshheading:8690792-Macaca mulatta, pubmed-meshheading:8690792-Male, pubmed-meshheading:8690792-Middle Aged, pubmed-meshheading:8690792-Plasminogen, pubmed-meshheading:8690792-Protein Binding, pubmed-meshheading:8690792-Sepharose
pubmed:year
1996
pubmed:articleTitle
Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
pubmed:affiliation
Department of Medicine, University of Chicago, Illinois 60637, USA. oklezovi@medicine.bsd.uchicago.edu
pubmed:publicationType
Journal Article
More...